Artivion Inc (AORT)vsStryker Corporation (SYK)
AORT
Artivion Inc
$19.40
-3.48%
HEALTHCARE · Cap: $998.73M
SYK
Stryker Corporation
$318.79
-2.01%
HEALTHCARE · Cap: $111.11B
Smart Verdict
WallStSmart Research — data-driven comparison
Stryker Corporation generates 5358% more annual revenue ($26.30B vs $481.88M). SYK leads profitability with a 13.8% profit margin vs -3.6%. SYK appears more attractively valued with a PEG of 1.37. SYK earns a higher WallStSmart Score of 57/100 (C).
AORT
Hold35
out of 100
Grade: F
SYK
Buy57
out of 100
Grade: C
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-28.3%
Fair Value
$31.25
Current Price
$19.40
$11.85 premium
Margin of Safety
-38.2%
Fair Value
$235.85
Current Price
$318.79
$82.94 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Large-cap with strong market position
Strong operational efficiency at 20.3%
Generating 1.2B in free cash flow
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Operating margin of 4.9%
Expensive relative to growth rate
Premium valuation, high expectations priced in
Weak financial health signals
Earnings declined 11.7%
Comparative Analysis Report
WallStSmart ResearchBull Case : AORT
The strongest argument for AORT centers on Price/Book.
Bull Case : SYK
The strongest argument for SYK centers on Market Cap, Operating Margin, Free Cash Flow. PEG of 1.37 suggests the stock is reasonably priced for its growth.
Bear Case : AORT
The primary concerns for AORT are EPS Growth, Market Cap, Operating Margin.
Bear Case : SYK
The primary concerns for SYK are P/E Ratio, Piotroski F-Score, EPS Growth.
Key Dynamics to Monitor
AORT profiles as a turnaround stock while SYK is a value play — different risk/reward profiles.
AORT carries more volatility with a beta of 1.28 — expect wider price swings.
AORT is growing revenue faster at 9.2% — sustainability is the question.
SYK generates stronger free cash flow (1.2B), providing more financial flexibility.
Bottom Line
SYK scores higher overall (57/100 vs 35/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Artivion Inc
HEALTHCARE · MEDICAL DEVICES · USA
Artivion Inc. manufactures, processes and distributes implantable human tissues and medical devices worldwide.
Stryker Corporation
HEALTHCARE · MEDICAL DEVICES · USA
Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment; neurosurgical, neurovascular and spinal devices; as well as other medical device products used in a variety of medical specialties.
Visit Website →Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?